Vasiliki E. Kalodimou is the head of the Flow Cytometry-Research and Regenerative Medicine Department at IASO Hospital in Athens, Greece.
She received her bachelor in Human Physiology and her master in Human Molecular Genetics from the Imperial College-University of Medicine in London, UK, and her PhD from University of Medicine in Athens, Greece, in stem cells and factors affecting their viability and absolute numbers.
She is an AABB (www.aabb.org), assessor from 2010.
Before joining IASO Hospital, Dr. Kalodimou was a scientific associate at General University Hospital of Heraklion, Crete, in the Haematology Department. In addition, she was an instructor at General University Hospital of Heraklion, and Ipokratios Medical-Technical Institute of Athens.
Since 2006, Dr. Kalodimou has studied and working with stem cells from placenta, umbilical cord and adipose tissue, in every day practice and their applications in regenerative medicine and Flow Cytometry. With many publications in the area, one published book about basics in flow Cytometry & book chapters, and 5 research fellowships in collaboration with state universities and pharmaceutical companies.
She is in collaboration with the Hellenic Flow Cytometry Society, having set QC schemes for stem cells markers enumeration. The purpose of Dr. Kalodimou work is to find new helpful application, evaluate the risk factors for infusion and try to make clear and easy to access measurements by flow Cytometry. Her work quantifies and ranks all risk of flow Cytometry enumeration to prevent and minimize the false positive results from different cytometer uses, make easier and accessible QC schemes for lab use and also she is working to establish combinations of monoclonal antibodies for mesenchymal and adipose tissue stem cell enumeration.